Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * |
Title | Home - Gibson |
Description | [et_pb_text _builder_version="4.17.4" |
Keywords | N/A |
WebSite | gibsononcology.com |
Host IP | 173.236.88.189 |
Location | United States |
Site | Rank |
US$1,061
Last updated: 2023-04-28 10:21:13
gibsononcology.com has Semrush global rank of 0. gibsononcology.com has an estimated worth of US$ 1,061, based on its estimated Ads revenue. gibsononcology.com receives approximately 122 unique visitors each day. Its web server is located in United States, with IP address 173.236.88.189. According to SiteAdvisor, gibsononcology.com is safe to visit. |
Purchase/Sale Value | US$1,061 |
Daily Ads Revenue | US$0 |
Monthly Ads Revenue | US$29 |
Yearly Ads Revenue | US$352 |
Daily Unique Visitors | 8 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
gibsononcology.com. | A | 597 | IP: 173.236.88.189 |
gibsononcology.com. | NS | 3600 | NS Record: ns35.domaincontrol.com. |
gibsononcology.com. | NS | 3600 | NS Record: ns36.domaincontrol.com. |
gibsononcology.com. | MX | 3600 | MX Record: 20 mx2-us1.ppe-hosted.com. |
gibsononcology.com. | MX | 3600 | MX Record: 10 mx1-us1.ppe-hosted.com. |
gibsononcology.com. | TXT | 3600 | TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com include:secureserver.net -all |
gibsononcology.com. | TXT | 3600 | TXT Record: NETORGFT3813245.onmicrosoft.com |
Facebook Twitter Instagram Home Our Story Our Team Management Mark C Rogers MD MBA Randall B Riggs Clifford T Solomon MD Elizabeth L Rogers MD Theodore C Solomon Mark D. Baganz, MD Fred Mermelstein Ph.D. Scientific Advisors Pooran Chand, PhD Mark S Cushman PhD PharmD Michael Zinner, MD Dr. Danzhou Yang Graeme F. Woodworth, MD Desmond A. Brown, MD, PhD Our Products References News Contact Us Select Page Gibson Oncology is developing a novel class of proprietary drug candidates currently in clinical trials for the treatment of difficult-to-treat tumors. Our product candidates are first-in-class based upon dual activity at C-MYC and Topo-1 which will improve safety and efficacy and offer future approaches for treating several cancers. There are currently five (5) ongoing clinical studies funded by the National Institutes of Health in patients with solid tumors and lymphomas. Finally, Gibson has developed proprietary second-generation product candidates expanding modes of delivery and |
HTTP/1.1 301 Moved Permanently Date: Thu, 21 Oct 2021 12:27:13 GMT Server: Apache X-Pingback: http://gibsononcology.com/xmlrpc.php Location: https://gibsononcology.com/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 406 Not Acceptable Date: Thu, 21 Oct 2021 12:27:15 GMT Server: Apache Content-Type: text/html; charset=UTF-8 |
Domain Name: GIBSONONCOLOGY.COM Registry Domain ID: 2230825078_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-02-23T19:36:02Z Creation Date: 2018-02-22T18:44:12Z Registry Expiry Date: 2022-02-22T18:44:12Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS35.DOMAINCONTROL.COM Name Server: NS36.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T06:08:25Z <<< |